scholarly journals Dermatologic manifestations of endocrine disorders

2017 ◽  
Vol 6 (4) ◽  
pp. 300-312 ◽  
Author(s):  
Michael Lause ◽  
Alisha Kamboj ◽  
Esteban Fernandez Faith
Keyword(s):  
Endocrine Disorders ◽  
Dermatologic Manifestations

scholarly journals Dermatologic Manifestations of Endocrine Disorders

Cureus ◽  
2021 ◽  
Author(s):  
Rishi Raj ◽  
Ghada Elshimy ◽  
Rahul Mishra ◽  
Nivedita Jha ◽  
Vismaya Joseph ◽  
...  
Keyword(s):  
Endocrine Disorders ◽  
Dermatologic Manifestations

Dermatologic manifestations of endocrine disorders

2012 ◽  
Vol 24 (4) ◽  
pp. 487-493 ◽  
Author(s):  
Nicola A. Quatrano ◽  
Karen J. Loechner
Keyword(s):  
Endocrine Disorders ◽  
Dermatologic Manifestations

scholarly journals TRICHOLOGY FEATURES OF ALOPECIA IN WOMEN OF REPRODUCTIVE AGE PATIENTS WITH POLYCYSTIC OVARY SYNDROM

2018 ◽  
Vol 2 (5) ◽  
pp. 9-14
Author(s):  
Лилия Беленькая ◽  
Liliya Belenkaya ◽  
Олег Иванов ◽  
Oleg Ivanov ◽  
Ольга Панарина ◽  
...  
Keyword(s):  
Polycystic Ovary ◽  
Reproductive Age ◽  
Endocrine Disorders ◽  
Androgenic Alopecia ◽  
General Physical Examination ◽  
General Physical ◽  
Systemic Examination ◽  
Dermatologic Manifestations ◽  
Reproductive Aged Women ◽  
The Impact

Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5–10 % of reproductive-aged women. The dermatologic manifestations of PCOS play a significant role in diagnosis. The purpose of the present study was to examine the impact of androgenic alopecia among patients with PCOS and to define their most significant trichological features. Because the data on dermatologic changes associated with PCOS are rather scarce, the present study was designed to determine the incidence and prevalence of androgenic alopecia. Materials and methods. We conducted a prospective observational study of patients with PCOS. The diagnosis of PCOS was made according to the consensus criteria adopted in May 2003 in Rotterdam. Each patient signed informed consent, and then a general physical examination, systemic examination, breast and pelvic examination, as well as a detailed trichological examination were carried out. Results. Twenty women with PCOS participated in the study. The median age was 28.7 ± 6.2 years. Oligo/anovulation frequency was 63.2 %, hirsutism frequency – 68.4 %. In our study, the prevalence of androgenic alopecia was found to be 30 %, telogenic hair loss – 55 %, absence of alopecia signs in 15 % of cases. Conclusions. Androgenic alopecia is a prevalent but unreliable marker of biochemical hyperandrogenism. It is therefore imperative for the treating physicians to understand the adverse effects associated with PCOS, recognize these potential health risks in patients, and treat them accordingly.

Assessment of endocrine disorders of the hypothalamicpituitary axis by nuclear medicine techniques

2002 ◽  
Vol 41 (02) ◽  
pp. 80-90 ◽  
Author(s):  
F. Jockenhövel ◽  
P. Theissen ◽  
M. Dietlein ◽  
W. Krone ◽  
H. Schicha ◽  
...  
Keyword(s):  
Nuclear Medicine ◽  
Pituitary Adenomas ◽  
Dopamine D2 Receptor ◽  
Somatostatin Receptor ◽  
D2 Receptor ◽  
Ectopic Acth Syndrome ◽  
Endocrine Disorders ◽  
Ectopic Acth ◽  
Number Of Patients ◽  
Hypothalamic Pituitary Axis

SummaryThe following article reviews nuclear medicine techniques which can be used for assessment of endocrine disorders of the hypothalamic-pituitary axis. For planar and SPECT imaging somatostatin-receptor- and dopamine- D2-receptor-scintigraphy are the most widely distributed techniques. These nuclear medicine techniques may be indicated in selected cases to answer differential diagnostic problems. They can be helpful to search for presence and localization of receptor positive tissue. Furthermore they can detect metastasis in the rare cases of a pituitary carcinoma. Scintigraphy with Gallium-67 is suitable for further diagnostic evaluation in suspected hypophysitis. Other SPECT radiopharmaca do not have relevant clinical significance. F-18-FDG as PET radiopharmacon is not ideal because obvious pituitary adenomas could not be visualized. Other PET radiopharmaca including C-11-methionine, C-11-tyrosine, F-18-fluoroethylspiperone, C-11-methylspiperone, and C-11-raclopride are available in specialized centers only. Overall indications for nuclear medicine in studies for the assessment of endocrine disorders of the hypothalamic-pituitary-axis are rare. Original studies often report only about a small number of patients. According to the authors’ opinion the relevance of nuclear medicine in studies of clinically important endocrinologic fields, e. g. localization of small ACTH-producing pituitary adenomas, tumor localization in ectopic ACTH syndrome, localization of recurrent pituitary tissue, assessment of small incidentalomas, can not be definitely given yet.

SKIN BIOPSY AND THYROTROPHIN ASSAY IN CHILDREN WITH ENDOCRINE DISORDERS, ESPECIALLY HYPOTHYROIDISM

1955 ◽  
Vol 18 (4) ◽  
pp. 557-559 ◽  
Author(s):  
Henning Andersen ◽  
Gustav Asboe-Hansen ◽  
Flemming Quaade ◽  
Robert Wichmann
Keyword(s):  
Skin Biopsy ◽  
Endocrine Disorders

PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM CORTICOSTEROID THERAPY

1966 ◽  
Vol 51 (1) ◽  
pp. 63-70 ◽  
Author(s):  
P. F. Roe ◽  
D. M. Mitchell ◽  
G. W. Pennington
Keyword(s):  
Corticosteroid Therapy ◽  
Adrenocortical Function ◽  
Endocrine Disorders ◽  
Marked Rise ◽  
Underlying Condition ◽  
Normal Limits ◽  
Small Rise ◽  
The Mean ◽  
Corticosteroid Drugs

ABSTRACT Adrenocortical function was assessed in 20 patients receiving long-term corticosteroid drugs for a variety of non-endocrine disorders. In all cases plasma 17-hydroxycorticosteroids (17-OHCS) levels were within or above normal limits 48 hours after abruptly stopping their drugs and a further marked rise occurred in 7 patients given metyrapone for 24 h. Urinary 17-OHCS excretion did not show a parallel rise. Taking the group as a whole, a small rise in the mean output occurred 48 hours after stopping therapy, and a further slightly greater rise followed metyrapone. 3 patients had a relapse of their underlying condition during the test in spite of normal plasma and urinary 17-OHCS levels.

Levels of vitamin D in patients with various endocrine disorders

2014 ◽  
Author(s):  
Ekaterina Pigarova ◽  
Larisa Dzeranova ◽  
Liudmila Rozhinskaya ◽  
Alexander Il'in ◽  
Galina Melnichenko
Keyword(s):  
Vitamin D ◽  
Endocrine Disorders

Endocrine disorders in treatment-naive male patients with HIV infection

2017 ◽  
Author(s):  
Nikolaos Kalogeris ◽  
Markella Nezi ◽  
Maria Chini ◽  
Athina Lioni ◽  
Vissaria Sakka ◽  
...  
Keyword(s):  
Hiv Infection ◽  
Endocrine Disorders ◽  
Treatment Naïve ◽  
Male Patients
Sign in / Sign up

Export Citation Format

Share Document